Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Christine Lebrun Frenay.
Neuroimmunology and Neuroinflammation | 2015
Christina Azevedo; Eve Overton; Sankalpa Khadka; Jessica Buckley; Shuang Liu; Mehul P. Sampat; Christine Lebrun Frenay; Aksel Siva; Darin T. Okuda; Daniel Pelletier
Objective: Increasing evidence indicates that the thalamus may be a location of early neurodegeneration in multiple sclerosis (MS). Our objective was to identify the presence of gray matter volume loss and thinning in patients with radiologically isolated syndrome (RIS). Methods: Sixty-three participants were included in this case-control study. Twenty-one patients with RIS were age- and sex-matched to 42 healthy controls in a 1:2 ratio. All participants underwent brain MRIs on a single 3T scanner. After lesion segmentation and inpainting, 1 mm3-isometric T1-weighted images were submitted to FreeSurfer (v5.2). Normalized cortical and deep gray matter volumes were compared between patients with RIS and controls using t tests, and thalamic volumes were correlated with white matter lesion volumes using Pearson correlation. Exploratory cortical thickness maps were created. Results: Although traditional normalized total gray and white matter volumes were not statistically different between patients with RIS and controls, normalized left (0.0046 ± 0.0005 vs 0.0049 ± 0.0004, p = 0.006), right (0.0045 ± 0.0005 vs 0.0048 ± 0.0004, p = 0.008), and mean (0.0045 ± 0.0005 vs 0.0049 ± 0.0004, p = 0.004) thalamic volumes were significantly lower in patients with RIS (n = 21, mean age 41.9 ± 12.7 years) than in controls (n = 42, mean age 41.4 ± 11.2 years). Thalamic volumes correlated modestly with white matter lesion volumes (range: r = −0.35 to −0.47). Conclusion: Our data provide novel evidence of thalamic atrophy in RIS and are consistent with previous reports in early MS stages. Thalamic volume loss is present early in CNS demyelinating disease and should be further investigated as a metric associated with neurodegeneration.
Neurology | 2015
Ayman Tourbah; Christine Lebrun Frenay; Gilles Edan; Michel Clanet; Caroline Papeix; Sandra Vukusic; Jérôme De Seze; Marc Debouverie; Olivier Gout; Pierre Clavelou; Gilles Defer; David Laplaud; Thibault Moreau; Pierre Labauge; Bruno Brochet; Frédéric Sedel; Jean Pelletier
Neurology | 2013
Mikael Cohen; Elisabeth Maillart; Caroline Papeix; Sandra Vukusic; David Brassat; Jérôme De Seze; Ayman Tourbah; Sandrine Wiertlewski; David Laplaud; Sylvie Courtois; Faycal Derouiche; Loic Chambaud; Clotilde Boulay; Bruno Brochet; Marc Debouverie; Olivier Casez; Olivier Heinzlef; J.-C. Ouallet; Bruno Stankoff; Giovanni Castelnovo; Emmanuelle Le Page; Gilles Defer; Nathalie Derache; Olivier Anne; Eric Berger; Lucien Rumbach; J.-P. Camdessanché; Audrey Kopf; Marie Fleury; Irina Malikova
Neurology | 2015
Darin T. Okuda; Christine Lebrun Frenay; Aksel Siva; Christophe Hotermans; Christian von Hehn; Gina Remington; Braeden D. Newton; Teresa C. Frohman; Elliot M. Frohman; Orhun Kantarci; Daniel Pelletier
Neurology | 2017
Lila Sirven-Villaros; V. Bourg; Lydiane Mondot; Denys Fontaine; Fanny Vandenbos; Christine Lebrun Frenay
Neurology | 2017
Christine Lebrun Frenay; Aksel Siva; Christina Azevedo; Maria Pia Sormani; Daniel Pelletier; Darin T. Okuda
Neurology | 2016
Naila Makhani; Christine Lebrun Frenay; Aksel Siva; Clarisse Carra-Dalliere; Jérôme De Seze; Francoise Durand Dubief; Orhun Kantarci; Megan Langille; Jean Pelletier; Juan Ignacio Rojas; Teri Schreiner; Mar Tintoré; Ugur Uygunoglu; Darin T. Okuda; Daniel Pelletier
Neurology | 2016
Mark T. Keegan; Yong Guo; Darin T. Okuda; Aksel Siva; Daniel Pelletier; Orhun Kantarci; Claudia F. Lucchinetti; Christine Lebrun Frenay
Neurology | 2016
Christine Lebrun Frenay; Mikael Cohen; Gwendoline Romero; Alessandra Rosenthal-Allieri; Michel Ticchioni
Neurology | 2016
Christine Lebrun Frenay; V. Bourg; Mikael Cohen; Alexandra Rosenthal; Claude Desnuelle; Michel Ticchioni